HPV Test Kits

PLEASE NOTE THAT THIS IS NOT A REQUEST FOR PROPOSAL AND NO SOLICITATION EXISTS AT THIS TIME. THIS ANNOUNCEMENT IS NOT A SOLICITATION AND IS BEING USED FOR THE PURPOSE OF MARKET ANALYSIS ONLY. This notice is being published in accordance with Federal Acquisition Regulations (FAR) Part 10.001(a)(2)(i) which requires conducting market research before developing new requirements. The Government is seeking industry's input to determine the availability of sources of Pap test kits that allow for Human Papillomavirus (HPV) testing. Respondents are requested to submit the information listed below via email. Respondents are encouraged to provide their product catalog. Responding Business Identification Information Firm Name and Physical Address: CAGE Code: Contact for Firm: Name, Title, Phone Number, and E-mail Address: Business Size: Product Information: What types of HPV kits does your company provide and what equipment (if any) is required to process the results of the test kits? If testing equipment is required to analyze the kits, are the equipment(s) available for sale and/or lease? Where are the products manufactured (i.e. - Country of Origin)? Is your company able to provide support to CONUS, OCONUS and/or AHP customers? All responses to this RFI must be provided as an attachment in an e-mail message addressed to the Point of Contacts (POC) below, with the subject line - Response to HPV RFI no later than 13 October 2023. No contract awards will be made from this notice and no solicitation is available on SAM.gov or any other bulletin board, posting room, or clearinghouse at this time. Participation in this effort is strictly voluntary. All costs associated with responding to this RFI will be solely at the respondent's expense. The Government will not reimburse costs and will not be liable for any costs associated with responses to this RFI. Respondents will not be notified of the responses to this notice. Responses are not considered offers and cannot be accepted by the Government to form a binding contract. Requested information will be used within DLA and will not be disclosed outside the agency.